Has Feds approve new HPV vaccine for cervical cancer?
WASHINGTON (CNN) — The Food and Drug Administration approved a second vaccine intended to protect against cervical cancer. GlaxoSmithKline has manufactured a vaccine for the prevention of cervical cancer. GlaxoSmithKline has manufactured a vaccine for the prevention of cervical cancer. Cervarix, manufactured by GlaxoSmithKline, was approved Friday for prevention of cervical cancer and pre-cancerous lesions caused by human papillomavirus (HPV) types 16 and 18.